Et profilbilde

Professor
Frederic Emmanuel Bouder { "honorific-suffix": "Professor", "fn": "Frederic Emmanuel Bouder", "tel": "", "email": "frederic.bouder@uis.no" }

Faculty Faculty of Science and Technology
Department Department of Safety, Economics and Planning

Frederic Bouder is Professor in Risk Management. He has developed extensive work on risk policy from a comparative perspective. His awareness of the role that new modes of governance and the media play in policy making has made risk communication a central pillar of his research. He has integrated cognitive insights from decision science into making risk policy more science-informed.

Research fields

Conceptual and applied Risk Communication (Pharma, H&S, Food, Environment) Conceptual and applied Risk Policy (Pharma, H&S, Food, Environment) 

Selected publications

  • Hansson, M. G., Bouder, F., & Howard, H. C. (2018). Genetics and risk ? an exploration of conceptual approaches to genetic risk. Editorial article. Journal of Risk Research, 21(2), 101-108. DOI: 10.1080/13669877.2017.1382562

    Bouder, F. (2018). Towards a Concept of Genetic Risk Tolerance: a risk analysis perspective. Journal of Risk Research, 21(2), 190-205. DOI: 10.1080/13669877.2017.1391314

    Rothstein, H., Demeritt, D., Paul, R., Beaussier, A-L., Wesseling, M., Howard, M., ... Bouder, F.(2017). Varieties of risk regulation in Europe: coordination, complementarity and occupational safety in capitalist welfare states. Socio-Economic Review. DOI: 10.1093/ser/mwx029

    Bouder, F. (2017). STS and the understanding of risk. In H. van Lente, T. Swierstra, S. Wyatt, & R. Zeiss (Eds.), Wegwijs in STS - Knowing your Way in STS (pp. 131-135). Universiteit Maastricht.

    Lofstedt, R., & Bouder, F. (2017). Evidence-based uncertainty analysis: What should we now do in Europe? A view point. Journal of Risk Research, 1-20. DOI: 10.1080/13669877.2017.1316763

    Bouder, F., & Hesselbein, C. (2016). Foreward: Improving risk policy in Europe: Dutch experiences. Journal of Risk Research, 19(8), 1005-q006. DOI: 10.1080/13669877.2016.1168620

    Bouder, F., & Michiels van Kessenich, A. (2016). Vermaatschappelijking besluitvorming biedt perspectief. Tijdschrift Milieu, (1), 16-17.

    Way, D., Bouder, F., Löfstedt, R., & Evensen, D. (2016). Transparency of medicines data and safety issues-a European/US study of doctors? opinions: What does the evidence show?Journal of Risk Research. DOI: 10.1080/13669877.2015.1121911

    Way, D., Bouder, F., Löfstedt, R. E., & Evensen, D. (2016). Medicines transparency at the European Medicines Agency (EMA) in the information age: the perspective of patients. Journal of Risk Research, 19(9), 1185-1215. DOI: 10.1080/13669877.2016.1200652

    Way, D., Blazsin, H., Löfstedt, R. E., & Bouder, F. (2016). Pharmaceutical Benefit?Risk Communication Tools: A Review of the Literature. Drug Safety, 40(1), 15-36. DOI: 10.1007/s40264-016-0466-1

    Holt, D., Bouder, F., Elemuva, C., Gaedicke, G., Khamesipour, A., Kisler, B., Kochhar, S., Kutalek, R., Maurer, W., Obermeier, P., Seeber, L., Trusko, B., Gould, S. and Rath, B. (2016). The Importance of the Patient Voice in Vaccination and Vaccine Safety- Are we Listening? Clinical Microbiology and Infection 22 (5):146?S153.

    Bouder, F. (2015). Communicating Vaccine Safety to the Media and General Public, Special isssue Vaccine Safety Communication, Current Drug Safety, 2015(10): 9-15.

    Bouder, F., Löfstedt, R., Way, D., Evensen, D. (2015). Transparency in Europe: A Quantitative Study, Risk Analysis, 35(7):1210?1229.


Research in progress

Frederic Bouder's ongoing research activities focus on understanding critical policy decisions, particularly in the context of contested technologies. He is collaborating with other research organisations as well as regulatory agencies and other players to further the understanding of risk communication and policy in several sectors (Pharmaceuticals, Food, Environment, Health and Safety). Key areas of interest also include Transparency and Uncertainty. 

Research grants:

2018-2020. Making University of Stavanger the European research hub for teaching risk in Schools (Søknad om programområde innen forskning). Offering a 2 year scientific roadmap to support a risk scientific approach to education policy

2014-2019. MindTheRisk. Tolerability of Genetic Risks

Major six year project funded by the Swedish Foundation for Humanities and Social Sciences and co-ordinated by the Centre for Ethics and Bioethics, Uppsala University. As PI I am investigating the regulatory implications of provision of risk information from genetic and related technologies.

Work experience

Throughout his academic career, Frederic Bouder has developed research on risk policy and risk communication, with a strong European and transatlantic dimension. Frequently, his research has focused on critical decisions that fall within a grey area where the benefits for society are clearly recognizable but where simultaneously the risks are perceived as significant. He has built strong collaborations with 1- Regulatory agencies (FDA,EMA and European National Competent Authorities, HSE, IenM, EFSA) 2- Networks of experts on both sides of the Atlantic 3-Industry players especially in the medical, food and energy sectors 4- Consumers and Patient Groups (e.g. European Patients' Forum, ViVi) and 5- International organisations (OECD, World Bank, EPO).

Scientific publications (from Cristin)

  • Bouder, Frederic Emmanuel (2018). Influence of societal trends on risk communication. IMACE/FEDIOL; 2018-06-15 - 2018-06-16.
  • Bouder, Frederic Emmanuel (2018). Interview fr TTVest at SRA Nordic meeting. [TV]; 2018-11-09.
  • Bouder, Frederic Emmanuel (2018). Keynote talk: Risk communication in the 21st century: challenges and opportunities for regulators. Statens Legemiddelverk (NoMA); 2018-09-23.
  • Bouder, Frederic Emmanuel (2018). Panelist , part-taking in panel discussion on Uncertainty. Julie Girling MEP; 2018-05-22.
  • Bouder, Frederic Emmanuel (2018). Plenary session Chair. SRAE; 2018-06-18 - 2018-06-20.
  • Bouder, Frederic Emmanuel (2018). Risk Communication: what have we achieved and what are the current challenges for Pharma?. AstraZeneca; 2018-09-26.
  • Bouder, Frederic Emmanuel (2018). Risk Communication: what have we achieved and what are the current challenges for Pharma. DIA Europe; 2018-04-17 - 2018-04-21.
  • Bouder, Frederic Emmanuel (2018). Risk Policy in the 21st Century. UiS SEROS; 2018-09-13.
  • Bouder, Frederic Emmanuel (2018). Risk Policy in the 21st Century: Towards a safer world? Plenary talk. SRA Nordic; 2018-11-08 - 2018-11-09.
  • Bouder, Frederic Emmanuel (2018). Risk Science and Decision Science for Children and Teenagers. Meeting organiser and co-chair. UiS - Frederic Bouder; 2018-10-08 - 2018-10-12.
  • Bouder, Frederic Emmanuel (2018). Risk and Crisis Communication in the 21st Century. European Food Safety Authority; 2018-04-11.
  • Bouder, Frederic Emmanuel (2018). Risk and Crisis Communication in the 21st Century. Bfr and EFSA; 2018-03-07.
  • Bouder, Frederic Emmanuel (2018). Risk communication and policy in the 21st century: science informed. UiS SEROS; 2018-01-07.
  • Bouder, Frederic Emmanuel (2018). Risk-Science in the post Trump post Brexit environment: what can we learn?. Institute for Advanced Sustainability Study (IASS); 2018-06-29 - 2018-06-30.
  • Bouder, Frederic Emmanuel (2018). Roundtable chair and speaker: Educating Kids to Risk: What Can be Done, What has been Done and What Remains to be Done. Society for Risk Analysis; 2018-12-02 - 2018-12-06.
  • Bouder, Frederic Emmanuel (2018). Roundtable speaker: Europe after Brexit? Consequences for Risk Analysis. SRAE Benelux; 2018-03-26.
  • Bouder, Frederic Emmanuel (2018). Science-informed risk governance in the 21st century: Lessons from Europe and beyond. Norwegian Directorate for Civil Protection (DSB); 2018-11-28.
  • Bouder, Frederic Emmanuel (2018). Session Chair: : Risk management education and practice, part IV. SRAE; 2018-06-18 - 2018-06-20.
  • Bouder, Frederic Emmanuel (2018). Supporting a Risk Scientific Approach to Education Policy : a Systematic Review. SRAE; 2018-06-18 - 2018-06-20.
  • Bouder, Frederic Emmanuel (2018). The Evolving Role of Science for Policy Under Uncertainty: What have we learnt post Trump and Brexit?. Vrije Universiteit (VU); 2018-06-12 - 2018-12-14.
  • Bouder, Frederic Emmanuel (2018). The evolving role of science for policy analysis: a transatlantic study. Gothenburg Research Institute (GRI); 2018-02-28 - 2018-03-02.
  • Bouder, Frederic Emmanuel; Aven, Terje (2018). Webinar Core subjects of risk analysis: Risk management and governance. SRA; 2018-08-01.
  • Bouder, Frederic Emmanuel; Karlsson, Mikael (2018). Risk Science and the Regulatory Environment - SRA Podcast series. Society for Risk Analysis. [Internet]; 2018-07-16.
  • Hansson, Mats G.; Bouder, Frederic Emmanuel; Howard, Heidi C. (2018). Genetics and risk- an exploration of conceptual approaches to genetic risk.